Important progress has been made in understanding how immunity is elicited against
Toxoplasma gondii–a complex pathogen with multiple mechanisms of immune evasion …

Toxoplasmosis caused by the protozoan Toxoplasma gondii is a major public health
problem, infecting one-third of the world human beings, and leads to abortion in domestic …

Vaccines against parasites have lagged centuries behind those against viral and bacterial
infections, despite the devastating morbidity and widespread effects of parasitic diseases …

Toxoplasma gondii is an intracellular parasite that infects a broad range of animal species
and humans. As the main surface antigen of the tachyzoite, SAG1 is involved in the process …

Current study deals with a novel multi-epitope vaccine designed in silico and its confirmation
experiments for potential efficacy in BALB/c mice. Major histocompatibility complex (MHC) …

Infections with the intracellular protozoan parasite Toxoplasma gondii pose a serious public
health problem and are of great economic importance worldwide. The parasite rhoptry …

The ideal vaccine to protect against toxoplasmosis in humans would include antigens that
elicit a protective T helper cell type 1 immune response, and generate long-lived IFN-γ …

Ginsenoside, the most important component isolated from Panax ginseng, exhibits a variety
of biological activities. Particularly, ginsenoside Rg1 is known to have immune-modulating …

Background Toxoplasma gondii is a widespread intracellular parasite, which infects most
vertebrate animal hosts and causes zoonotic infection in humans. Vaccine strategy remains …

Streptococcus pneumoniae and influenza A virus (IAV) are significant agents of pneumonia
cases and severe respiratory infections globally. Secondary bacterial infections, particularly …